Company news: Physicians Interactive, Boehringer Ingelheim

Share this article:

Physicians Interactive named Dr. Gautam Gulati Chief Medical Officer and SVP of product management. Gulati will be overseeing product development lines. He was previously SVP at Digitas Health. Joe Caso was named EVP of new business. Caso's marketing focus will include marketing strategies that will retain prescription momentum for drugs that are aging out of their patent protection. Caso has worked with King Pharmaceuticals, Pfizer and Schering-Plough.

An anonymous physician complaint prompted the UK Prescription Medicines Code of Practice Authority to come down on German drug maker Boehringer Ingelheim, InPharm reported Thursday. The government agency found that BI's professional website for the blood thinner Pradaxa did not clearly indicate where users could find prescribing information. Instead, the site requires users to click the clinical indication, a location the doctor said was buried in promotional information. PMPCA agreed. 
Share this article:
close

Next Article in News

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.